Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
27
MYSZ Quote, Financials, Valuation and Earnings
Last price:
$0.87
Seasonality move
:
-38.63%
Day range:
$0.86 - $0.92
52-week range:
$0.73 - $3.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.30x
P/B ratio:
0.46x
Volume:
163K
Avg. volume:
217.7K
1-year change:
-67.59%
Market cap:
$3.3M
Revenue:
$8.3M
EPS (TTM):
-$1.41
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $142K | $131K | $4.5M | $7M | $8.3M | |
| Revenue Growth (YoY) | 125.4% | -7.75% | 3303.82% | 56.9% | 18.03% | |
| Cost of Revenues | $84K | -- | $4.2M | $4.3M | $4.9M | |
| Gross Profit | $58K | -- | $306K | $2.7M | $3.3M | |
| Gross Profit Margin | 40.85% | -- | 6.86% | 39.04% | 40.25% | |
| R&D Expenses | $1.5M | $4.2M | $1.7M | $974K | $429K | |
| Selling, General & Admin | $4.8M | $6.5M | $7M | $7.8M | $6.5M | |
| Other Inc / (Exp) | -$32K | -$296K | -$622K | -$713K | -$450K | |
| Operating Expenses | $6.2M | $10.6M | $8.4M | $8.8M | $6.9M | |
| Operating Income | -$6.1M | -$10.6M | -$8.1M | -$6.1M | -$3.6M | |
| Net Interest Expenses | $7K | -- | $236K | -- | $51K | |
| EBT. Incl. Unusual Items | -$6.2M | -$10.5M | -$8.3M | -$6.7M | -$4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$36K | -$333K | -- | |
| Net Income to Company | -$6.2M | -$10.5M | -$8.3M | -$6.4M | -$4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.2M | -$10.5M | -$8.3M | -$6.4M | -$4M | |
| Basic EPS (Cont. Ops) | -$222.29 | -$200.20 | -$59.79 | -$20.01 | -$4.39 | |
| Diluted EPS (Cont. Ops) | -$222.29 | -$200.20 | -$59.79 | -$20.01 | -$4.39 | |
| Weighted Average Basic Share | $27.7K | $52.5K | $139K | $318.8K | $910.8K | |
| Weighted Average Diluted Share | $27.7K | $52.5K | $139K | $318.8K | $910.8K | |
| EBITDA | -$6.1M | -$10.5M | -$7.8M | -$5.6M | -$3.1M | |
| EBIT | -$6.1M | -$10.6M | -$8.1M | -$6.1M | -$3.6M | |
| Revenue (Reported) | $142K | $131K | $4.5M | $7M | $8.3M | |
| Operating Income (Reported) | -$6.1M | -$10.6M | -$8.1M | -$6.1M | -$3.6M | |
| Operating Income (Adjusted) | -$6.1M | -$10.6M | -$8.1M | -$6.1M | -$3.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $31K | $726K | $2.2M | $1.8M | $2.6M | |
| Revenue Growth (YoY) | -64.77% | 2241.94% | 196.97% | -14.7% | 39.86% | |
| Cost of Revenues | -- | $927K | $780K | $1M | $1.6M | |
| Gross Profit | -- | -$201K | $1.4M | $791K | $1M | |
| Gross Profit Margin | -- | -27.69% | 63.82% | 43.01% | 39.23% | |
| R&D Expenses | $462K | $350K | $242K | $89K | $131K | |
| Selling, General & Admin | $1.6M | $1.5M | $2.2M | $1.4M | $2.2M | |
| Other Inc / (Exp) | -- | -- | -$9K | -$631K | -- | |
| Operating Expenses | $2M | $1.8M | $2.5M | $1.5M | $2.4M | |
| Operating Income | -$2M | -$2M | -$1.1M | -$675K | -$1.4M | |
| Net Interest Expenses | -- | $51K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$2M | -$2M | -$1.1M | -$1.3M | -$1.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $40K | -- | -- | |
| Net Income to Company | -$2M | -$1.9M | -$1M | -$1.3M | -$1.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2M | -$2M | -$1.1M | -$1.3M | -$1.3M | |
| Basic EPS (Cont. Ops) | -$26.69 | -$15.80 | -$3.54 | -$1.25 | -$0.40 | |
| Diluted EPS (Cont. Ops) | -$26.69 | -$15.80 | -$3.54 | -$1.25 | -$0.40 | |
| Weighted Average Basic Share | $75.2K | $128.2K | $319.9K | $1M | $3.3M | |
| Weighted Average Diluted Share | $75.2K | $128.2K | $319.9K | $1M | $3.3M | |
| EBITDA | -$2M | -$1.9M | -$977K | -$503K | -$1.2M | |
| EBIT | -$2M | -$2M | -$1.1M | -$675K | -$1.4M | |
| Revenue (Reported) | $31K | $726K | $2.2M | $1.8M | $2.6M | |
| Operating Income (Reported) | -$2M | -$2M | -$1.1M | -$675K | -$1.4M | |
| Operating Income (Adjusted) | -$2M | -$2M | -$1.1M | -$675K | -$1.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $91K | $2M | $6.7M | $9.6M | $7.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $5.2M | $5.4M | $4.6M | |
| Gross Profit | -- | $178K | $1.5M | $4.2M | $2.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.3M | $1.6M | $1.4M | $515K | $432K | |
| Selling, General & Admin | $5.4M | $7.3M | $7.9M | $7.3M | $6.3M | |
| Other Inc / (Exp) | -- | -- | -$48K | -$1.3M | -- | |
| Operating Expenses | $9.6M | $8.6M | $9M | $7.8M | $6.7M | |
| Operating Income | -$9.6M | -$8.4M | -$7.5M | -$3.5M | -$3.8M | |
| Net Interest Expenses | $36K | $198K | $184K | $87K | $25K | |
| EBT. Incl. Unusual Items | -$9.5M | -$8.6M | -$7.6M | -$4.7M | -$3.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$236K | -$133K | -- | |
| Net Income to Company | -$9.7M | -$8.7M | -$7.2M | -$4.5M | -$3.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.5M | -$8.6M | -$7.5M | -$4.6M | -$3.6M | |
| Basic EPS (Cont. Ops) | -$171.11 | -$69.58 | -$34.19 | -$20.48 | -$1.41 | |
| Diluted EPS (Cont. Ops) | -$171.11 | -$69.58 | -$34.19 | -$20.48 | -$1.41 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$9.5M | -$8.2M | -$7M | -$3.1M | -$3.5M | |
| EBIT | -$9.6M | -$8.4M | -$7.5M | -$3.5M | -$3.8M | |
| Revenue (Reported) | $91K | $2M | $6.7M | $9.6M | $7.5M | |
| Operating Income (Reported) | -$9.6M | -$8.4M | -$7.5M | -$3.5M | -$3.8M | |
| Operating Income (Adjusted) | -$9.6M | -$8.4M | -$7.5M | -$3.5M | -$3.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $88K | $1.9M | $4.2M | $6.8M | $6.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.8M | $2.8M | $3.8M | $3.5M | |
| Gross Profit | -- | $178K | $1.3M | $3M | $2.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.8M | $1.2M | $811K | $352K | $355K | |
| Selling, General & Admin | $4.1M | $4.9M | $5.8M | $5.2M | $5.1M | |
| Other Inc / (Exp) | -- | -- | -$48K | -$631K | -- | |
| Operating Expenses | $7.9M | $5.9M | $6.5M | $5.6M | $5.4M | |
| Operating Income | -$7.9M | -$5.7M | -$5.2M | -$2.6M | -$2.9M | |
| Net Interest Expenses | $27K | $198K | $146K | $87K | -- | |
| EBT. Incl. Unusual Items | -$7.8M | -$5.9M | -$5.2M | -$3.3M | -$2.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$200K | -- | -- | |
| Net Income to Company | -$7.9M | -$5.7M | -$4.9M | -$3.3M | -$3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.8M | -$5.9M | -$5.1M | -$3.3M | -$2.8M | |
| Basic EPS (Cont. Ops) | -$123.55 | -$46.94 | -$21.18 | -$17.60 | -$1.05 | |
| Diluted EPS (Cont. Ops) | -$123.55 | -$46.94 | -$21.18 | -$17.60 | -$1.05 | |
| Weighted Average Basic Share | $187.7K | $379.4K | $823.2K | $1.9M | $8.5M | |
| Weighted Average Diluted Share | $187.7K | $379.4K | $823.2K | $1.9M | $8.5M | |
| EBITDA | -$7.8M | -$5.5M | -$4.8M | -$2.2M | -$2.6M | |
| EBIT | -$7.9M | -$5.7M | -$5.2M | -$2.6M | -$2.9M | |
| Revenue (Reported) | $88K | $1.9M | $4.2M | $6.8M | $6.1M | |
| Operating Income (Reported) | -$7.9M | -$5.7M | -$5.2M | -$2.6M | -$2.9M | |
| Operating Income (Adjusted) | -$7.9M | -$5.7M | -$5.2M | -$2.6M | -$2.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2M | $10.9M | $2.4M | $2.3M | $4.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $28K | $40K | $1.9M | $615K | $278K | |
| Inventory | -- | -- | $997K | $2.9M | $2.8M | |
| Prepaid Expenses | $413K | $429K | $322K | $87K | $332K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.5M | $11.6M | $6.1M | $6.6M | $9.1M | |
| Property Plant And Equipment | $1M | $888K | $723K | $472K | $90K | |
| Long-Term Investments | $59K | $108K | $146K | $30K | $7K | |
| Goodwill | -- | -- | $1.4M | $758K | $133K | |
| Other Intangibles | -- | -- | $1.4M | $1.1M | $750K | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.6M | $12.6M | $9.7M | $9.3M | $10.2M | |
| Accounts Payable | $381K | $635K | $2.5M | $2.2M | $2.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $155K | $158K | $107K | |
| Current Portion Of Capital Lease Obligations | $129K | $138K | $159K | $158K | $15K | |
| Other Current Liabilities | $1K | -- | -- | -- | -- | |
| Total Current Liabilities | $911K | $1.2M | $4.2M | $3.9M | $3M | |
| Long-Term Debt | $579K | $473K | $684K | $378K | $154K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.5M | $1.7M | $5.2M | $4.5M | $3.3M | |
| Common Stock | $7K | $24K | $1K | $4K | $2K | |
| Other Common Equity Adj | -$424K | -$406K | -$637K | -$771K | -$825K | |
| Common Equity | $2.1M | $10.9M | $4.5M | $4.7M | $6.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2.1M | $10.9M | $4.5M | $4.7M | $6.9M | |
| Total Liabilities and Equity | $3.6M | $12.6M | $9.7M | $9.3M | $10.2M | |
| Cash and Short Terms | $2M | $10.9M | $2.4M | $2.3M | $4.9M | |
| Total Debt | $579K | $473K | $684K | $378K | $154K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.8M | $4.6M | $3.8M | $2.4M | $4.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $37K | $386K | $690K | $327K | $506K | |
| Inventory | -- | $1.1M | $2.4M | $2.2M | $3.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4M | $6.7M | $8.1M | $5.9M | $9.1M | |
| Property Plant And Equipment | $900K | $803K | $484K | $93K | $85K | |
| Long-Term Investments | $105K | $80K | $73K | $7K | $14K | |
| Goodwill | -- | $268K | $1.4M | $131K | -- | |
| Other Intangibles | -- | $294K | $1.1M | $845K | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5M | $8.2M | $11.2M | $7M | $11.7M | |
| Accounts Payable | $556K | $749K | $2.6M | $1.3M | $1.3M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $230K | $123K | -- | |
| Current Portion Of Capital Lease Obligations | $130K | $177K | $137K | $16K | -- | |
| Other Current Liabilities | -- | $28K | -- | -- | -- | |
| Total Current Liabilities | $1.4M | $2.1M | $4.6M | $2.4M | $3.3M | |
| Long-Term Debt | $493K | $454K | $424K | $189K | $832K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.9M | $2.7M | $5.3M | $2.6M | $4.4M | |
| Common Stock | $15K | $26K | $3K | $1K | $4K | |
| Other Common Equity Adj | -$432K | -$584K | -$712K | -$896K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.1M | $5.5M | $5.9M | $4.5M | $7.3M | |
| Total Liabilities and Equity | $5M | $8.2M | $11.2M | $7M | $11.7M | |
| Cash and Short Terms | $3.8M | $4.6M | $3.8M | $2.4M | $4.5M | |
| Total Debt | $493K | $454K | $424K | $189K | $832K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.2M | -$10.5M | -$8.3M | -$6.4M | -$4M | |
| Depreciation & Amoritzation | $82K | $85K | $328K | $466K | $461K | |
| Stock-Based Compensation | $645K | $373K | $455K | $453K | $390K | |
| Change in Accounts Receivable | -$142K | -$111K | -$1.7M | $1.1M | $67K | |
| Change in Inventories | -- | -- | -$219K | -$1.8M | $112K | |
| Cash From Operations | -$5.7M | -$7.3M | -$7.3M | -$6.1M | -$3.1M | |
| Capital Expenditures | $41K | $23K | $27K | $7K | $7K | |
| Cash Acquisitions | -- | -- | $767K | -- | -- | |
| Cash From Investing | -$41K | -$23K | -$993K | -$7K | $53K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $500K | |
| Long-Term Debt Repaid | -- | -- | -$67K | -$124K | -$735K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6.1M | $16.3M | -$67K | $6.1M | $5.6M | |
| Beginning Cash (CF) | $2M | $10.9M | $2.4M | $2.3M | $4.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $478K | $9M | -$8.6M | -$99K | $2.6M | |
| Ending Cash (CF) | $2.5M | $19.9M | -$6.4M | $2M | $7.6M | |
| Levered Free Cash Flow | -$5.7M | -$7.3M | -$7.3M | -$6.1M | -$3.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2M | -$1.9M | -$1M | -$1.3M | -$1.5M | |
| Depreciation & Amoritzation | $20.3K | $47.7K | $120K | $172.3K | $161.3K | |
| Stock-Based Compensation | $119.9K | $158.7K | $62.4K | $89.6K | $19.5K | |
| Change in Accounts Receivable | $79.8K | $83.2K | -$111K | -$197.8K | $102K | |
| Change in Inventories | -- | $165.5K | -$1.4M | -$440.6K | -$464.6K | |
| Cash From Operations | -$1.3M | -$1.7M | -$1.2M | -$454.2K | -$617K | |
| Capital Expenditures | $100 | $1.7K | -- | -- | $700 | |
| Cash Acquisitions | -- | -$2.3K | -- | -- | $150.3K | |
| Cash From Investing | -$184.4K | $600 | -- | $300 | -$150.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $350K | -- | -- | |
| Long-Term Debt Repaid | -- | -$15K | -$315K | -$335K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $53.5K | -$14.4K | $3.5M | -$320.9K | $934.6K | |
| Beginning Cash (CF) | $3.8M | $4.6M | $3.8M | $2.4M | $4.5M | |
| Foreign Exchange Rate Adjustment | $6K | -$290.5K | $149.2K | -$121.2K | $29.3K | |
| Additions / Reductions | -$1.5M | -$2M | $2.5M | -$896.1K | $196.2K | |
| Ending Cash (CF) | $2.4M | $2.3M | $6.4M | $1.4M | $4.7M | |
| Levered Free Cash Flow | -$1.3M | -$1.7M | -$1.2M | -$454.2K | -$617.7K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.7M | -$8.7M | -$7.2M | -$4.5M | -$3.7M | |
| Depreciation & Amoritzation | $88K | $165.2K | $545.2K | $479.2K | $331.3K | |
| Stock-Based Compensation | $623.4K | $346.8K | $401.9K | $461.1K | $173K | |
| Change in Accounts Receivable | -$21K | -$602.7K | -$691.5K | $408K | $218.3K | |
| Change in Inventories | -- | -$288K | -$1.4M | $337.8K | -$992.2K | |
| Cash From Operations | -$6M | -$9.1M | -$6.1M | -$3.6M | -$3.5M | |
| Capital Expenditures | $40.2K | $37.6K | -$200 | $6.8K | $23.8K | |
| Cash Acquisitions | -- | $290.9K | $447.6K | -- | $195.5K | |
| Cash From Investing | -$14.7K | -$328.5K | -$639K | $53K | -$211.7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $332K | $150K | -- | |
| Long-Term Debt Repaid | -- | -$57K | -$387K | -$440K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6M | $10.8M | $6M | $2.5M | $5.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.5K | $1.2M | -$772.2K | -$1.3M | $2.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$6.1M | -$9.2M | -$6.1M | -$3.7M | -$3.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.9M | -$5.7M | -$4.9M | -$3.3M | -$3M | |
| Depreciation & Amoritzation | $63.4K | $141.5K | $370.9K | $400.4K | $270.8K | |
| Stock-Based Compensation | $352.3K | $317K | $280.8K | $304.8K | $87.8K | |
| Change in Accounts Receivable | $352.3K | -$136.7K | $788.3K | $119.6K | $270.8K | |
| Change in Inventories | -- | -$279.2K | -$1.5M | $630.5K | -$473.6K | |
| Cash From Operations | -$4M | -$5.7M | -$4.8M | -$2.5M | -$2.9M | |
| Capital Expenditures | $12.1K | $26.1K | -- | -- | $16.8K | |
| Cash Acquisitions | -- | $290.9K | -- | -- | $195.5K | |
| Cash From Investing | -$12.1K | -$317.1K | -- | $59.8K | -$205K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $18K | $350K | $500K | -- | |
| Long-Term Debt Repaid | -- | -$57K | -$377K | -$693K | -$42K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $5.9M | -$37.9K | $6M | $2.6M | $2.8M | |
| Beginning Cash (CF) | $14.9M | $19.5M | $7.7M | $6.9M | $12.5M | |
| Foreign Exchange Rate Adjustment | -$10K | -$94K | $81.3K | -$55.7K | -$99.3K | |
| Additions / Reductions | $1.9M | -$6.1M | $1.4M | $106.6K | -$404.7K | |
| Ending Cash (CF) | $16.8M | $13.2M | $9.1M | $6.9M | $12M | |
| Levered Free Cash Flow | -$4M | -$5.7M | -$4.8M | -$2.5M | -$3M | |
Get MYSZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MYSZ
Sector
P/E ratio
--
24.38x
PEG ratio
--
0.00x
P/B ratio
0.46x
2.23x
Price / LTM sales
0.30x
1.42x
Growth Metrics
MYSZ
Sector
Revenue growth
39.86%
6.6%
Earnings growth
67.76%
10.85%
Revenue (5-year growth)
165.15%
4.81%
Earnings forecast
-$0.32
$0.15
Profitability
MYSZ
Sector
Profitability FY 2024
$3.3M
$29M
Return on invested capital
-52.24%
-0.65%
Return on assets
-37.44%
-1.48%
Return on equity
-55.44%
0.22%
Earnings Date
Last Earnings Date
Jan
19
Next Earnings Date
Jan
19
Estimated Next Earnings Date
Apr
20
Balance Sheet
MYSZ
Sector
Total cash
$4.5M
$38.6M
Short term investments
--
$16.2M
Total assets
$10.2M
$153.8M
Long term debt
$832K
$4.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 15
Argan, Inc. [AGX] is down 0% over the past day.
Buy
80
ASTS alert for Jan 15
AST Spacemobile, Inc. [ASTS] is down 0% over the past day.
Buy
84
IREN alert for Jan 15
IREN Ltd. [IREN] is down 0% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
